Castle Biosciences, Inc.
USD23.72
-0.60 (-2.47%)
CEO
Derek J. Maetzold
IPO Date
2019-07-25
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$24.14
Prev. Close
$24.32
Day Low
$23.50
Day High
$24.26
52W Low
$14.59
52W High
$44.28
Market Cap
$0.72B
Volume
0.01M
| 550 |
| $2.39 |
| 17 Jun 2026 | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | S-Sale | Disposed | 550 | $20.66 |
| 17 Jun 2026 | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | S-Sale | Disposed | 1,357 | $20.66 |
| 17 Jun 2026 | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | S-Sale | Disposed | 1,153 | $20.66 |
| 17 Jun 2026 | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | S-Sale | Disposed | 278 | $20.66 |
| 17 Jun 2026 | MAETZOLD DEREK J | director, officer: Pres. & Chief Exec. Officer | M-Exempt | Disposed | 550 | $2.39 |
| 1 Jun 2026 | Olson Tiffany | director | A-Award | Acquired | 11,766 | $0.00 |
| 1 Jun 2026 | Goldberg Ellen | director | A-Award | Acquired | 11,766 | $0.00 |
| 1 Jun 2026 | Harrison Miles | director | A-Award | Acquired | 11,766 | $0.00 |
| $1,001 - $15,000 |